• $80.1M
    Market Cap
  • 347.89%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
49.9M
+0.46%
49.7M
-21.36%
63.2M
-14.82%
74.1M
-22.85%
Cost of Revenue
28.2M
-0.74%
28.4M
+2.96%
27.6M
-49.59%
54.7M
+15.20%
Gross Profit
21.7M
+2.07%
21.3M
-40.22%
35.6M
+83.23%
19.4M
-60.05%
Sales and Marketing Expense
42.0M
-21.18%
53.2M
-29.60%
75.6M
+7.95%
70.1M
-28.25%
Research and Development Expense
-1.8M
-22.60%
-2.3M
-21.32%
-3.0M
-13.71%
-3.4M
-37.57%
Depreciation and Amortization Expense
6.3M
-36.64%
10.0M
-34.18%
15.2M
+69.05%
9.0M
-18.66%
Total Operating Expenses
28.2M
-0.74%
28.4M
+2.96%
27.6M
-49.59%
54.7M
+15.20%
Operating Profit
-20.3M
-36.64%
-32.0M
-21.24%
-40.6M
-22.62%
-52.5M
-64.31%
Interest Income
N/A
N/A
0
-100.00%
10.7M
N/A
N/A
N/A
Interest Expense
-5.1M
+9.10%
-4.6M
+9.65%
-4.2M
+682.29%
-542,000
N/A
Interest Income and Expense and Net
-5.1M
+9.10%
-4.6M
-171.97%
6.5M
+1,291.88%
-542,000
N/A
Total Nonoperating Income and Expense
-2.3M
-245.18%
1.6M
+158.09%
-2.7M
-462.10%
744,000
+1,358.82%
Income before Taxes
-29.8M
+0.007%
-29.8M
+28.11%
-23.3M
-60.71%
-59.2M
-56.95%
Income Taxes
-68,000
-274.36%
39,000
-92.63%
529,000
+481.32%
91,000
-36.36%
Extraordinary Items
N/A
N/A
0
-100.00%
548,000
-70.17%
1.8M
-98.13%
Net Income
-29.7M
-0.35%
-29.8M
+25.42%
-23.8M
-59.88%
-59.3M
-56.93%
Net Income from Continuing Operations Applicable to Common
-29.8M
+0.007%
-29.8M
+28.11%
-23.3M
-60.71%
-59.2M
-56.95%
Basic EPS and Net Income
-0.19
0.00%
-0.19
+18.75%
-0.16
-60.00%
-0.40
-59.18%
Diluted EPS and Net Income
-0.19
0.00%
-0.19
+18.75%
-0.16
-60.00%
-0.40
-59.18%
Basic Weighted Average Shares
158.8M
+0.78%
157.6M
+3.02%
152.9M
+4.30%
146.6M
+4.16%
Diluted Weighted Average Shares
158.8M
+0.78%
157.6M
+3.02%
152.9M
+4.30%
146.6M
+4.16%
Balance Sheet
Cash and Cash Equivalents
8.0M
-64.48%
22.6M
-52.70%
47.8M
-28.59%
67.0M
+243.51%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.0M
-64.48%
22.6M
-52.70%
47.8M
-28.59%
67.0M
+243.51%
Total Current Assets
30.4M
-35.38%
47.0M
-39.90%
78.2M
-24.66%
103.8M
+8.30%
Accumulated Depreciation
30.9M
+13.67%
27.2M
+15.56%
23.6M
+23.94%
19.0M
+37.41%
Property and Plant and Equipment and Net
22.7M
-13.89%
26.3M
-4.27%
27.5M
-6.20%
29.3M
-18.72%
Total Long-Term Assets
22.7M
+3,488.45%
632,000
-10.10%
703,000
-87.82%
5.8M
+179.83%
Total Assets
75.3M
-33.65%
113.4M
-25.64%
152.5M
-18.70%
187.6M
+9.40%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
8.7M
-45.66%
15.9M
-32.61%
23.6M
+10.36%
21.4M
+6.23%
Total Long-Term Debt
50.8M
+16.54%
43.6M
+2.59%
42.5M
+13.65%
37.4M
N/A
Total Long-Term Liabilities
12.2M
-10.74%
13.7M
-12.79%
15.7M
-12.57%
17.9M
-12.66%
Total Liabilities
77.3M
-10.47%
86.4M
-10.97%
97.0M
-11.94%
110.1M
+168.19%
Retained Earnings
-331.3M
+9.86%
-301.6M
+10.98%
-271.7M
+9.60%
-247.9M
+31.45%
Total Stockholders Equity
-2.0M
-107.53%
27.1M
-51.25%
55.6M
-28.32%
77.5M
-40.58%
Total Shares Outstanding
159.4M
+0.89%
158.0M
+2.38%
154.3M
+1.44%
152.1M
+5.17%
Cash Flow
Cash from Operating Activities
-14.1M
-33.58%
-21.3M
+38.18%
-15.4M
+189.48%
-5.3M
-82.02%
Capital Expenditures
549,000
-85.74%
3.9M
+4.33%
3.7M
+1,292.83%
265,000
-94.61%
Cash from Investing Activities
-412,000
-89.15%
-3.8M
+8.27%
-3.5M
-987.59%
395,000
+103.35%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-50,000
-65.52%
-145,000
-42.23%
-251,000
-100.48%
52.4M
+551.69%
Financials Ratio
Gross Margin
43.49%
+1.60%
42.81%
-23.99%
56.32%
+115.09%
26.18%
N/A
Operating Margin
-40.62%
-36.93%
-64.40%
+0.15%
-64.31%
-9.17%
-70.79%
N/A
Return on Assets
-31.52%
+40.45%
-22.44%
+60.41%
-13.99%
-57.64%
-33.03%
N/A
Return on Equity
-237.47%
+228.79%
-72.23%
+101.94%
-35.77%
-37.30%
-57.05%
N/A
Revenue Growth
0.46%
+102.17%
-21.36%
+44.15%
-14.82%
-35.15%
-22.85%
N/A
Current Ratio
3.51
+18.92%
2.95
-10.82%
3.31
-31.73%
4.84
N/A
Cash Ratio
0.93
-34.62%
1.42
-29.82%
2.02
-35.29%
3.13
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow